Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15320203 | 0.80 | MGLL (0.40) | — | |
| SCHEMBL9116242 | 0.73 | NPY4R (0.32) | — | |
| SCHEMBL11039765 | 0.73 | GSR (0.31) | — | |
| SCHEMBL9699505 | 0.71 | MGLL (0.30) | — | |
| SCHEMBL1832989 | 0.70 | GSR (0.44) | CPB2 | |
| SCHEMBL30469023 | 0.69 | CPB2 (0.39) | CPB2 | |
| SCHEMBL14577995 | 0.66 | MGLL (0.37) | — | |
| SCHEMBL17104494 | 0.65 | MGLL (0.31) | — | |
| SCHEMBL31509482 | 0.64 | CPB2 (0.43) | CPB2 | |
| SCHEMBL555855 | 0.63 | DPP7 (0.51) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0305409-B1 | SOLUBILIZATION OF PROTEINS FOR PHARMACEUTICAL COMPOSITIONS USING POLYPROLINE CONJUGATION | CETUS ONCOLOGY CORPORATION (US) | 1991-10-30 | — | — | EP | claimed |
| EP-0305409-A1 | SOLUBILIZATION OF PROTEINS FOR PHARMACEUTICAL COMPOSITIONS USING POLYPROLINE CONJUGATION. | CETUS CORP (US) | 1989-03-08 | — | — | EP | claimed |
| WO-1988003412-A1 | SOLUBILIZATION OF PROTEINS FOR PHARMACEUTICAL COMPOSITIONS USING POLYPROLINE CONJUGATION | CETUS CORPORATION (US) | 1988-05-19 | — | — | WO | claimed |
| EP-0451141-B1 | IMMOBILIZED SEQUENCE-SPECIFIC PROBES | HOFFMANN LA ROCHE (CH) | 1998-11-18 | — | — | EP | disclosed |
| US-5541065-A | AMPLIFYING NUCLEIC ACID SEQUENCE FROM EXON TWO OF HUMAN LEUKOCYTE ANTIGEN DPBETA GENE IN SAMPLE, MIXING WITH PANEL OF SEQUENCE SPECIFIC OLIGONUCLEOTIDE PROBES, DETECTING HYBRIDS FORMED, DETERMINING GENOTYPE | HOFFMANN-LA ROCHE INC. (US) | 1996-07-30 | — | — | US | disclosed |
| US-5310893-A | Oligonucleotide probe | HOFFMANN-LA ROCHE INC. (US) | 1994-05-10 | — | — | US | disclosed |
| EP-0575845-A2 | Method for HLA-DP typing | F. HOFFMANN-LA ROCHE AG (CH) | 1993-12-29 | — | — | EP | disclosed |
| EP-0380559-B1 | OLIGONUCLEOTIDE FUNCTIONALIZING REAGENTS AND METHODS | CETUS ONCOLOGY CORP (US) | 1993-12-22 | — | — | EP | disclosed |
| EP-0451141-A1 | IMMOBILIZED SEQUENCE-SPECIFIC PROBES | F. HOFFMANN-LA ROCHE AG (CH) | 1991-10-16 | — | — | EP | disclosed |
| WO-1991004753-A1 | CONJUGATES OF ANTISENSE OLIGONUCLEOTIDES AND THERAPEUTIC USES THEREOF | CETUS CORPORATION (US) | 1991-04-18 | — | — | WO | disclosed |
| EP-0417160-A1 | METHOD FOR HLA DP TYPING. | CETUS CORP (US) | 1991-03-20 | — | — | EP | disclosed |
| US-4962029-A | Covalent oligonucleotide-horseradish peroxidase conjugate | CETUS CORPORATION (US) | 1990-10-09 | — | — | US | disclosed |
| EP-0380559-A1 | OLIGONUCLEOTIDE FUNCTIONALIZING REAGENTS AND METHODS. | CETUS CORP (US) | 1990-08-08 | — | — | EP | disclosed |
| EP-0372002-A1 | A COVALENT OLIGONUCLEOTIDE-HORSERADISH PEROXIDASE CONJUGATE | CETUS ONCOLOGY CORPORATION (US) | 1990-06-13 | — | — | EP | disclosed |
| WO-1989011548-A1 | IMMOBILIZED SEQUENCE-SPECIFIC PROBES | CETUS CORPORATION (US) | 1989-11-30 | — | — | WO | disclosed |
| WO-1989011547-A1 | METHOD FOR HLA DP TYPING | CETUS CORPORATION (US) | 1989-11-30 | — | — | WO | disclosed |
| WO-1989002931-A1 | OLIGONUCLEOTIDE FUNCTIONALIZING REAGENTS AND METHODS | CETUS CORPORATION (US) | 1989-04-06 | — | — | WO | disclosed |
| WO-1989002932-A1 | A COVALENT OLIGONUCLEOTIDE-HORSERADISH PEROXIDASE CONJUGATE | CETUS CORPORATION (US) | 1989-04-06 | — | — | WO | disclosed |